Comments:A 1-year long strike against FMC Novamed: Women workers allege unfair treatment
This page is for commentary on the news. If you wish to point out a problem in the article (e.g. factual error, etc), please use its regular collaboration page instead. Comments on this page do not need to adhere to the Neutral Point of View policy. You should sign your comments by adding ~~~~ to the end of your message. Please remain on topic. Though there are very few rules governing what can be said here, civil discussion and polite sparring make our comments pages a fun and friendly place. Please think of this when posting.
Quick hints for new commentators:
- Use colons to indent a response to someone else's remarks
- Always sign your comments by putting --~~~~ at the end
- You can edit a section by using the edit link to the right of the section heading
This article is biased in a number of ways.
The single English language source for this article if from a union activist group, and the article is largely a rehash of union positions. Despite requests, the author never marked the article ready for review by other editors. The author did not address a number of items identified on the talk page.
There are also a number of factual errors in the article. Citing NO english language sources, the author claims Novamed has a monopoly on the dialysis market. This appears to be false. Using actual financial reports, they appear to have 30% international market share in dialysis products. With Baxter at 22%. In terms of providers, they are 1.5 times as large as DeVita.
There is likely a story here as the treatment sounds terrible, but this article reads too much like a union press release. A strong reporting effort would have fleshed out the company position as well and involved some basic fact-checking.